Search

everythinglearnresearchcommunity

for

Search:↓

The new AI software predicts melanoma outcomes more accurately than traditional methods.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Hair turning darker can be a sign of skin cancer.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Melanoma research shifted focus to immunotherapy drugs after 2010, increasing their study and citations.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

EGFR inhibitors for lung cancer can cause severe skin issues.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Melanin granules can be expelled by exocytosis.

Gefitinib can cause hair and eyebrow darkening.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Patient-derived stem cell melanocytes could be a promising treatment for vitiligo.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The environment around melanocyte stem cells is key for hair regeneration and color, with certain injuries affecting hair color and potential treatments for pigmentation disorders.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

MC-1R in skin cells may influence inflammation and collagen production.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

A new mouse model effectively mimics vitiligo for research and drug testing.